NCT03519204View on ClinicalTrials.gov

Safety and Effectiveness of JUVÉDERM® VOLBELLA® With Lidocaine for Lip Enhancement in Chinese Adults

NACompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

January 28, 2016

Primary Completion Date

March 30, 2018

Study Completion Date

March 30, 2018

Conditions
Lip Enhancement
Interventions
DEVICE

JUVÉDERM® VOLBELLA® XC with Lidocaine

JUVÉDERM® VOLBELLA® XC with lidocaine injected into lips.

OTHER

No-treatment Control

No-treatment was administered.

Trial Locations (5)

100029

China-Japan Friendship Hospital, Beijing

100083

Peking University Third Hospital, Beijing

430000

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

510010

General Hospital of Southern Theatre Command, Guangzhou

510515

Nanfang Hospital, Southern Medical University, Guangzhou

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY

NCT03519204 - Safety and Effectiveness of JUVÉDERM® VOLBELLA® With Lidocaine for Lip Enhancement in Chinese Adults | Biotech Hunter | Biotech Hunter